Infectious Diseases

STRIVE to Control Ebola

The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) has started recruiting volunteers to test for the effectiveness of the vaccine. About 6,000 healthcare and other frontline workers will be enrolled in STRIVE to receive the rVSV-ZEBOV vaccine, which uses the vesicular stomatitis virus to carry a non-infectious Zaire ebola virus gene, hopefully inducing an immune response from the recipients.

This trial is being conducted by the Centers for Disease Control and Prevention (CDC) in partnership with the Sierra Leone College of Medicine and Allied Health Sciences and the Ministry of Health and Sanitation.

Only time shall tell whether this vaccine is the long awaited preventive tool we have been asking for against the killer virus.

Skeptic Oslerphile. Public Health Scientist and Program Manager, Translational Global Health Policy Research Cell, Department of Health Research, Ministry of Health and Family Welfare, Government of India. Past: Scientist, Indian Council of Medical Research, National Institute of Cholera and Enteric Diseases; Senior Research Associate, Public Health Foundation of India. Interests include: Emerging Infections, Public Health, Antimicrobial Resistance, One Health and Zoonoses, Diarrheal Diseases, Medical Education, Medical History, Open Access, Healthcare Social Media and Health2.0. Opinions are my own!

0 comments on “STRIVE to Control Ebola

Debates and Discussions...

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: